glaxosmithkline plc

Abbott Laboratories Settles, Again

Health Care Renewal  Wed, 04/20/2011 - 15:40

In 2007, we discussed a scheme that Abbott Laboratories seemed to be using to boost the price of Kaletra, a combination of two protease inhibitors it markets to treat HIV and AIDS.

Kaletra is a combination of rinoavir (Norvir, sold by Abbott as a single drug), and leponavir. Kaletra was apparently losing sales to the combination of Norvir with Reyataz (atazanavir), made by Bristol-Myers-Squibb.

So Abbott increased the price of Norvir by 400%.


 

GSK scraps plans to market prostate-cancer drug

Headlines from the Associated Press  Wed, 03/23/2011 - 10:01

LONDON (AP) -- Drug giant GlaxoSmithKline PLC says it will no longer pursue global regulatory approval to market its Avodart drug to treat prostate cancer following negative feedback from American and Swedish regulators....


 

Breakthrough on cystic fibrosis 1 step closer as new research al...

EurekAlert! - Medicine and Health  Wed, 01/26/2011 - 23:00

(McGill University) McGill University and GlaxoSmithKline PLC have signed a collaboration agreement to develop a potential breakthrough approach to treat cystic fibrosis, a fatal genetic disease.

The trans-Atlantic effort between researchers from McGill's Faculty of Medicine and their GSK collaborators in the UK, will focus on developing molecules that could treat the disease by correcting the dysfunction caused by the mutated gene.


 

Glaxo CEO: Time to diversify, help poor countries

Headlines from the Associated Press  Tue, 02/02/2010 - 15:56

NEW YORK (AP) -- Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare conglomerate, a strategy most rivals now are pursuing....


 

Batch of swine flu vaccines studied in Canada

Headlines from the Associated Press  Tue, 11/24/2009 - 11:22

LONDON (AP) -- Canadian doctors have been advised not to use a batch of 170,000 doses of swine flu vaccine while authorities investigate reports of allergic reactions among recipients, drug maker GlaxoSmithKline PLC said Tuesday....


 

GlaxoSmithKline pulls swine flu vaccines in Canada

Headlines from the Associated Press  Tue, 11/24/2009 - 07:06

LONDON (AP) -- Pharmaceuticals company GlaxoSmithKline PLC said Tuesday it has advised medical staff in Canada to not use one batch of swine flu vaccines in case they trigger life-threatening allergies....


 

UK to Force Drugmakers to Share Info

Headlines from the Associated Press  Mon, 03/24/2008 - 15:49

LONDON (AP) -- Britain plans to force pharmaceutical companies to share more information with regulators about clinical trials after an investigation recently concluded that GlaxoSmithKline PLC deliberately withheld information about an antidepressant....